Total assets · 2011–2025
Biocryst Pharmaceuticals total assets
$514M+4.8% · FY2025
Biocryst Pharmaceuticals (BCRX) reported $514M in total assets for fiscal 2025, +4.8% year on year.
| Fiscal year | Total assets | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $514M | +4.8% | Open → |
| FY20242024-12-31 | $490M | −5.1% | Open → |
| FY20232023-12-31 | $517M | −6.0% | Open → |
| FY20222022-12-31 | $550M | −6.5% | Open → |
| FY20212021-12-31 | $588M | +75.7% | Open → |
| FY20202020-12-31 | $335M | +91.0% | Open → |
| FY20192019-12-31 | $175M | +19.4% | Open → |
| FY20182018-12-31 | $147M | −17.6% | Open → |
| FY20172017-12-31 | $178M | +98.4% | Open → |
| FY20162016-12-31 | $89.8M | −26.6% | Open → |
| FY20152015-12-31 | $122M | −10.6% | Open → |
| FY20142014-12-31 | $137M | +180.1% | Open → |
| FY20132013-12-31 | $48.9M | −14.9% | Open → |
| FY20122012-12-31 | $57.4M | −30.1% | Open → |
| FY20112011-12-31 | $82.2M | — | Open → |
Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +14.0%
Total assets at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Biocryst Pharmaceuticals total assets |url=https://companiesranked.com/en/company/biocryst-pharmaceuticals/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Biocryst Pharmaceuticals total assets. CompaniesRanked. https://companiesranked.com/en/company/biocryst-pharmaceuticals/total-assetsBibTeX
@misc{companiesranked-en-company-biocryst-pharmaceuticals-total-assets-2026,
author = {{CompaniesRanked}},
title = {{Biocryst Pharmaceuticals total assets}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/biocryst-pharmaceuticals/total-assets}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001628280-26-053300 · August 5, 2026
{{cite web |title=Biocryst Pharmaceuticals total assets — 10-Q (0001628280-26-053300) |url=https://www.sec.gov/Archives/edgar/data/882796/000162828026053300/bcrx-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.